165 related articles for article (PubMed ID: 18065664)
1. Parenteral immunization of mice with a genetically inactivated pertussis toxin DNA vaccine induces cell-mediated immunity and protection.
Fry SR; Chen AY; Daggard G; Mukkur TKS
J Med Microbiol; 2008 Jan; 57(Pt 1):28-35. PubMed ID: 18065664
[TBL] [Abstract][Full Text] [Related]
2. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity.
Redhead K; Watkins J; Barnard A; Mills KH
Infect Immun; 1993 Aug; 61(8):3190-8. PubMed ID: 8335349
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and protective efficacy of a newly developed tri-component diphtheria, tetanus, and acellular pertussis vaccine in a murine model.
Huh DH; Han SB; Shin HJ; Ahn DH; Choi GS; Kang KR; Kim BR; Kang JH
J Microbiol Immunol Infect; 2018 Dec; 51(6):732-739. PubMed ID: 28720318
[TBL] [Abstract][Full Text] [Related]
4. DNA vaccine encoding pertussis toxin S1 subunit induces protection against Bordetella pertussis in mice.
Kamachi K; Konda T; Arakawa Y
Vaccine; 2003 Nov; 21(31):4609-15. PubMed ID: 14575775
[TBL] [Abstract][Full Text] [Related]
5. Neonatal immunization with a single dose of recombinant BCG expressing subunit S1 from pertussis toxin induces complete protection against Bordetella pertussis intracerebral challenge.
Nascimento IP; Dias WO; Quintilio W; Christ AP; Moraes JF; Vancetto MD; Ribeiro-Dos-Santos G; Raw I; Leite LC
Microbes Infect; 2008 Feb; 10(2):198-202. PubMed ID: 18248757
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of efficacy in terms of antibody levels and cell-mediated immunity of acellular pertussis vaccines in a murine model of respiratory infection.
Watanabe M; Komatsu E; Sato T; Nagai M
FEMS Immunol Med Microbiol; 2002 Jul; 33(3):219-25. PubMed ID: 12110485
[TBL] [Abstract][Full Text] [Related]
7. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0.
Barnard A; Mahon BP; Watkins J; Redhead K; Mills KH
Immunology; 1996 Mar; 87(3):372-80. PubMed ID: 8778021
[TBL] [Abstract][Full Text] [Related]
8. Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells.
Ryan EJ; McNeela E; Murphy GA; Stewart H; O'hagan D; Pizza M; Rappuoli R; Mills KH
Infect Immun; 1999 Dec; 67(12):6270-80. PubMed ID: 10569737
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte-macrophage colony-stimulating factor DNA prime-protein boost strategy to enhance efficacy of a recombinant pertussis DNA vaccine.
Li QT; Zhu YZ; Chu JY; Dong K; He P; Feng CY; Hu BY; Zhang SM; Guo XK
Acta Pharmacol Sin; 2006 Nov; 27(11):1487-94. PubMed ID: 17049126
[TBL] [Abstract][Full Text] [Related]
10. Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice.
Nascimento IP; Dias WO; Mazzantini RP; Miyaji EN; Gamberini M; Quintilio W; Gebara VC; Cardoso DF; Ho PL; Raw I; Winter N; Gicquel B; Rappuoli R; Leite LC
Infect Immun; 2000 Sep; 68(9):4877-83. PubMed ID: 10948100
[TBL] [Abstract][Full Text] [Related]
11. Development of safer pertussis DNA vaccine expressing non-toxic C180 polypeptide of pertussis toxin S1 subunit.
Kamachi K; Arakawa Y
Vaccine; 2007 Jan; 25(6):1000-6. PubMed ID: 17050047
[TBL] [Abstract][Full Text] [Related]
12. Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine.
Podda A; Bona G; Canciani G; Pistilli AM; Contu B; Furlan R; Meloni T; Stramare D; Titone L; Rappuoli R
J Pediatr; 1995 Aug; 127(2):238-43. PubMed ID: 7636648
[TBL] [Abstract][Full Text] [Related]
13. A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in adults.
Leroux-Roels G; Lattanzi M; Solis CD; Contorni M; Costantini M; Moraschini L; Bardelli M; Bertholet S; Borgogni E; Buricchi F; Cantisani R; Faenzi E; Finco O; Leuzzi R; Pizza M; Rosa D; Schiavetti F; Seubert A; Spensieri F; Volpini G; Zedda L; Giudice GD; Galgani I
Hum Vaccin Immunother; 2018 Jan; 14(1):45-58. PubMed ID: 29172945
[TBL] [Abstract][Full Text] [Related]
14. Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles.
van der Lee S; Hendrikx LH; Sanders EAM; Berbers GAM; Buisman AM
Front Immunol; 2018; 9():51. PubMed ID: 29416544
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of chosen parameters of immuno response in mice immunized with whole-cell or acellular pertussis vaccines and challenged with B. pertussis strains harbouring different ptxS1/prn allele genes combinations].
Gzyl A; Augustynowicz E; Zawadka M; Rabczenko D; Slusarczyk J
Med Dosw Mikrobiol; 2007; 59(2):137-47. PubMed ID: 17929411
[TBL] [Abstract][Full Text] [Related]
16. Whole-cell or acellular pertussis vaccination in infancy determines IgG subclass profiles to DTaP booster vaccination.
van der Lee S; Sanders EAM; Berbers GAM; Buisman AM
Vaccine; 2018 Jan; 36(2):220-226. PubMed ID: 29199041
[TBL] [Abstract][Full Text] [Related]
17. Pertussis vaccine: a critique.
Robbins JB; Schneerson R; Keith JM; Miller MA; Kubler-Kielb J; Trollfors B
Pediatr Infect Dis J; 2009 Mar; 28(3):237-41. PubMed ID: 19165133
[TBL] [Abstract][Full Text] [Related]
18. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.
Mills KH; Ryan M; Ryan E; Mahon BP
Infect Immun; 1998 Feb; 66(2):594-602. PubMed ID: 9453614
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells.
Mahon BP; Ryan MS; Griffin F; Mills KH
Infect Immun; 1996 Dec; 64(12):5295-301. PubMed ID: 8945580
[TBL] [Abstract][Full Text] [Related]
20. Acellular and whole cell pertussis vaccines protect against the lethal effects of intracerebral challenge by two different T-cell dependent humoral routes.
Wiertz EJ; Walvoort HC; Van Loveren H; Van Straaten-Van De Kappelle I; Van Der Gun JW; Kreeftenberg JG
Biologicals; 1990 Jul; 18(3):173-80. PubMed ID: 2257130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
